Christian Schnell - Department of Oncology, Novartis Institutes for Biomedical Research

Ana-Leticia Maragno,Katherine Seiss, Rick Newcombe,Prakash Mistry,Christian R. Schnell, Fabian Von Arx, Julie Koenig, Anthony S. Malamas,Gaetane Le Toumelin-Braizat, Laura Bresson,Francesca Rocchetti,Didier Demarles, Esther Kurth, Lorena Renteria,Dominik Hainzl, Volker Engelhardt, Caroline Liot, Vincent Madelain, Vesela Kostova, Jerome-Benoit Starck, Damien Valour, Georges-Alain Franzetti,Frederic Colland, Helena Vostiarova,William R. Tschantz, Nicholas Bachmann, Sebastian Palacio-Ramirez,Matthew Burger, Jennifer M. Campbell,Zhuoliang Chen, Robert Koenig,Eric Mcneill, Ruowei Mo, Katsumasa Nakajima,Mark Palermo, Yiping Shen, Bing Yu, Mark Zambrowski,Alan Zhang,Frederic Zecri, Alberto Broniscer,Olivier Geneste, Kristin Horton,Joseph A. D'Alessio

BLOOD (2024): 1381-1382

Cited0Views0Bibtex

Abstract IA022: DYP688, a First-in-class PMEL17-targeted Antibody Drug Conjugate Delivering a Gq/11-specific Inhibitor for the Treatment of Metastatic Uveal Melanoma

Molecular Cancer Therapeuticsno. 12_Supplement (2024)

Cited0Views0Bibtex

Supplementary Table 1 from Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT

Neil A. O'Brien, Karen McDonald,Luo Tong,Erika von Euw,Ondrej Kalous,Dylan Conklin,Sara A. Hurvitz,Emmanuelle di Tomaso,Christian Schnell,Ronald Linnartz,Richard S. Finn,Samit Hirawat,Dennis J. Slamon

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn